Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer’s disease models

Journal:

Science Translational Medicine

Published:

2026-02-11

DOI:

10.1126/scitranslmed.adp3984

Affiliations:

6

Authors:

17

Go to article

Institutions	Authors	Share
Northwestern Medicine, United States of America (USA)	13.000000 13.000000	0.76
University of Gothenburg (GU), Sweden	2.500000	0.15
University Medical Center Göttingen (UMG), Germany	0.500000	0.03
University of Trieste (UNITS), Italy	0.500000	0.03
UCL Queen Square Institute of Neurology, United Kingdom (UK)	0.500000	0.03

Interested in Neurosciences?